Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.
1.How can I find information on impact factor, lead times, etc.?
View Diabetes' Vital Statistics for the latest information.
3. How can I contact the editorial office about a paper I've submitted?
You can check the status of your submission online at http://mc.manuscriptcentral.com/diabetes.
To reach the editorial office directly, please use the following contact information:
Phone: (310) 794-2858
Fax: (310) 794-3982
If you have been asked to send something to the editorial office, please use the following address (please note that Diabetes only takes manuscript submissions via the Web; see above):
Diabetes Editorial Office
5110 Commerce Square Drive, Suite G.
Indianapolis, IN 46237
4. How can I get permission to use copyrighted material from the journal?
Please click on "Get Permissions" to the right of the online version of an article. All permission requests, with the exception of translations, are processed through Copyright Clearance Center, and most are completed within 5 to 10 business days. For permission to translate, please send an e-mail containing the volume, issue, and page range of the article, the language, and the quantity to .
5. How can I order commercial reprints or e-prints?
Commercial reprint and e-print quote and order requests (quantities of 100 or more) should be directed to:
Content Sales Specialist
Sheridan Content Services
Phone: 800-635-7181 ext. 8065
Locate the article of interest and click the link for Full Text or Full Text (PDF); a page will open where subscribers may log in or short-term access may be purchased. If you do not have a subscription and wish to purchase access, select Purchase Short-Term Access. This option allows access to all content in the journal (from the computer you are currently using) for 30 days for $45. Visit this page from the same computer to regain access to a recent short-term access purchase if your access period has not yet expired.
To purchase a subscription or a single issue, visit ADA Journal Subscriptions.
8. How can I join ADA and become a Professional Member?
Visit the Professional Membership page for information on becoming a member or to access your membership account.
9. Whom can I contact with membership/subscription questions?
American Diabetes Association
1701 N. Beauregard St.
Alexandria, VA 22311
phone: toll-free 1-800-232-3472 ext. 2343; outside the U.S., 703-549-1500 ext. 2343, Monday through Friday 8:30 a.m. to 5:30 p.m. ET
View the Advertising & Reprints page for contact information and to view/download the latest advertising rate card.
ADA's Publications Policy Committee follows the recommendations of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), and the Committee on Publication Ethics (COPE) for guidance on policies and procedures related to publication ethics. The policies for Diabetes have been adopted from those three advisory bodies and, where necessary, modified and tailored to meet the specific content, audiences, and aims of Diabetes. Comprehensive information related to the editorial and ethical policies of Diabetes can be found in Publication Policies and Procedures for Diabetes. The Association's Publications Policy Committee or Subcommittee on Ethical Scientific Publications will consider on a case-by-case basis policies that are not addressed in the policies document, which contains information related to the following topics:
Diabetes participates in both LOCKSS and CLOCKSS.
LOCKSS is an open-source, library-led digital preservation system. The system allows libraries to obtain, preserve, and provide access to the e-content to which they subscribe, allowing institutions to build local collections. For more information, visit http://www.lockss.org/about/what-is-lockss/.
CLOCKSS is a geographically and geopolitically distributed network of redundant archive nodes, located at 12 major research libraries around the world, dedicated to the preservation of online journals. CLOCKSS provides for content to be freely available to everyone after a "trigger event" and ensures that online journal content will be maximally accessible and useful over time. For more information, visit http://www.clockss.org/clockss/Home.
The full-text of articles over 6 months old and dating back to 2000 are freely accessible; likewise, PDFs of articles over 12 months old and dating back to 2000 are freely accessible. In 2012, the journal made a significant investment to complete the journal's online archives by scanning and posting PDFs of articles published between 1952 and 1999. Those PDFs are accessible only to subscribers.